No registrations found.
ID
Source
Brief title
Health condition
Renal Mass;surgical treatment;minimal invasive
Sponsors and support
Intervention
Outcome measures
Primary outcome
To assess the current patterns of surgical or instrumental treatment and indications for RCC treatment.
Secondary outcome
1. To assess perioperative morbidity (30 days) by using the Clavien score;
2. To assess operative complications;
3. To define risk factors for the development of operative and peri-operative morbidity after instrumental treatment;
4. To asses the long term risk of renal insufficiency;
5. To asses pathological characteristics of the renal masses.
Background summary
Over the last 10 years, we have witnessed an increasing interest in the management of Renal masses. Three main reasons are responsible for this: the increasing diagnostic incidence which leads to the incidental discovery of small renal masses, the development and consolidation of partial nephrectomy and minimal invasive surgical treatments, the latter including both a laparoscopic approach and ablation techniques, and the increasing trend to nephron sparing surgery.
However, there are some fundamental differences concerning the indications for surgery and the technique used, mainly based on experience and institutional characteristics. Those factors may modulate outcomes. Similarly, specific patient and technical factors may influence treatment related morbidity.
In this prospective study we aim to assess on a global basis the indications for treatment and modality and outcomes of surgical treatment for renal masses including (laparoscopic/robotic) radical or partial nephrectomy and (percutaneous/laparoscopic assisted) ablative treatments. Each centre participating in this project will include during a one-year period all the patients treated at their site, with a diagnosis of a renal tumour or candidates for active surveillance (AS).
Study objective
To assess the current patterns of surgical or instrumental treatment and indications for RCC treatment.
Study design
One year inclusion of all data. Data will be collected prospectively. Variables will include preoperative assessment, operative data, histological results and postoperative period until 30 days.
Intervention
N/A
Inclusion criteria
Each centre participating in this project will include during a one-year period all the patients treated at their site, with a diagnosis of a renal tumour or candidates for active surveillance (AS).
Exclusion criteria
None.
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| NTR-new | NL1998 |
| NTR-old | NTR2115 |
| Other | CROES : 022010 |
| ISRCTN | ISRCTN wordt niet meer aangevraagd. |